NCT02700854View on ClinicalTrials.gov

Hypoxic-Ischemic Encephalopathy Therapy Optimization in Neonates for Better Neuroprotection With Inhalative CO2

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

September 30, 2019

Study Completion Date

November 30, 2019

Conditions
Hypoxic-Ischaemic EncephalopathyPerinatal AsphyxiaHypocapnia
Interventions
OTHER

5% carbon-dioxide inhalation

5% CO2 (36 mmHg) and 95% air gas mixture inhalation, for a maximum of 12 hours or until metabolic acidosis recovery occurs as measured by BE \> -5 mmol/L in arterial blood gas samples

Trial Locations (1)

1085

Semmelweis University, 1st Department of Pediatrics, Budapest

All Listed Sponsors
lead

Semmelweis University

OTHER

NCT02700854 - Hypoxic-Ischemic Encephalopathy Therapy Optimization in Neonates for Better Neuroprotection With Inhalative CO2 | Biotech Hunter | Biotech Hunter